181 related articles for article (PubMed ID: 20148501)
21. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
[TBL] [Abstract][Full Text] [Related]
22. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
23. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.
Rey E; LeLorier J; Burgess E; Lange IR; Leduc L
CMAJ; 1997 Nov; 157(9):1245-54. PubMed ID: 9361646
[TBL] [Abstract][Full Text] [Related]
24. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry.
Katz JN; Gore JM; Amin A; Anderson FA; Dasta JF; Ferguson JJ; Kleinschmidt K; Mayer SA; Multz AS; Peacock WF; Peterson E; Pollack C; Sung GY; Shorr A; Varon J; Wyman A; Emery LA; Granger CB;
Am Heart J; 2009 Oct; 158(4):599-606.e1. PubMed ID: 19781420
[TBL] [Abstract][Full Text] [Related]
25. Severe Asymptomatic Hypertension: Evaluation and Treatment.
Gauer R
Am Fam Physician; 2017 Apr; 95(8):492-500. PubMed ID: 28409616
[TBL] [Abstract][Full Text] [Related]
26. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
27. Nonemergent hypertension. New perspectives for the emergency medicine physician.
Thach AM; Schultz PJ
Emerg Med Clin North Am; 1995 Nov; 13(4):1009-35. PubMed ID: 7588185
[TBL] [Abstract][Full Text] [Related]
28. Managing hypertensive emergencies and urgencies in the geriatric patient.
Thacker HL; Jahnigen DW
Geriatrics; 1991 Oct; 46(10):26-30, 35-7. PubMed ID: 1916300
[TBL] [Abstract][Full Text] [Related]
29. [Rational treatment of hypertensive crises].
Juárez Herrera U
Arch Cardiol Mex; 2002; 72 Suppl 1():S95-9. PubMed ID: 12001881
[TBL] [Abstract][Full Text] [Related]
30. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
31. Hypertension crisis.
Papadopoulos DP; Mourouzis I; Thomopoulos C; Makris T; Papademetriou V
Blood Press; 2010 Dec; 19(6):328-36. PubMed ID: 20504242
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
33. [Recommendations for the management of hypertensive crisis. A Consensus document of the Chilean Society of Hypertension].
Valdés G; Roessler E;
Rev Med Chil; 2002 Mar; 130(3):322-31. PubMed ID: 12043377
[TBL] [Abstract][Full Text] [Related]
34. How do minor changes in the definition of blood pressure control affect the reported success of hypertension treatment?
Green BB; Kaplan RC; Psaty BM
Am J Manag Care; 2003 Mar; 9(3):219-24. PubMed ID: 12643339
[TBL] [Abstract][Full Text] [Related]
35. [Hypertension management in practice, 1986].
Weidmann P
Schweiz Med Wochenschr; 1986 Nov; 116(46):1592-7. PubMed ID: 2878492
[TBL] [Abstract][Full Text] [Related]
36. Towards a better yardstick: the choice of treatment thresholds in hypertension.
McAlister FA; Laupacis A
Can J Cardiol; 1998 Jan; 14(1):47-51. PubMed ID: 9487272
[TBL] [Abstract][Full Text] [Related]
37. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
Houston MC
Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
[TBL] [Abstract][Full Text] [Related]
38. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
[TBL] [Abstract][Full Text] [Related]
39. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
